Series C+ HealthTech & BioIntelligence Pitch Deck Benchmarks
Startup benchmarks for Series C+ HealthTech & BioIntelligence: Median Burn Multiple (1.2x), Gross Margin (74%), and Startup Health Score (92/100) across 162 real companies.
Audit Your Pitch Deck Before VCs See It
Check your burn multiple, unit economics, and capital efficiency against 162 real Series C+ HealthTech & BioIntelligence startups in 20 minutes.
Upload Pitch Deck for Free Audit →| Metric | P25 (Bottom 25%) | Median (50th) | P75 (Top 25%) | P90 (Top 10%) |
|---|---|---|---|---|
| Startup Health & Survivability Score (0-100) | 92 | 92 | 92 | 92 |
Verified statutory sample: 162 companies • Quorum requirement: N ≥ 25 • Updated: 2026-11-05
Frequently Asked Due Diligence Questions
What is a healthy burn multiple for a Series C+ HealthTech & BioIntelligence startup?
Across 162 verified companies, the median burn multiple is 1.2x. Startups in the top 25th percentile (most capital-efficient) operate at 0.8x or lower.
What startup health and survivability score do investors expect at Series C+?
The median startup health score is 92 out of 100. Top quartile companies reach 92 or higher before entering partner meetings.
How can I audit my pitch deck before pitching venture capital investors?
Founders can run an automated 20-minute pitch deck audit on EstiloFlow Vantage to stress-test unit economics, cash burn, and cap table dilution against real-world sector standards.